CCL2 and acute myeloid leukemia: Many of the ligands for these NK cell receptors are constitutively released by AML cells, including the chemokines within the CCL2–4/CXCL1/8 cluster found in most AML patients, indicating an expected migration of NK cells towards the AML blasts [112].